Older Maternal Age at First Delivery as a Risk Factor for Pelvic Organ Prolapse: What We Know.

Am J Obstet Gynecol

Department of Obstetrics and Gynecology, University of Utah, 30 N. Mario Capecchi Dr., Level 5 South, Salt Lake City, UT 84112.

Published: March 2025

Older chronological age and vaginal childbirth are widely accepted risk factors of pelvic organ prolapse (POP). However, considerably less attention has been given to the impact of maternal age at first delivery. Ample research has demonstrated the deleterious effects of age on the musculoskeletal system, including the loss of muscle mass and strength as well as diminished recovery after stress. Little research has evaluated the role of these local muscle changes in the development of POP when childbearing is delayed. As the average age of first-time mothers continues to increase, evaluating age at first delivery as a predictor of POP development is highly relevant. In this review, we present the evidence demonstrating that increased maternal age increases POP risk. Additionally, evidence regarding the effects of age at first delivery on mechanisms of POP including pelvic muscle dysfunction, levator ani defects, and genital hiatus enlargement is presented.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2025.03.006DOI Listing

Publication Analysis

Top Keywords

age delivery
16
maternal age
12
age
8
pelvic organ
8
organ prolapse
8
effects age
8
pop
5
older maternal
4
delivery
4
delivery risk
4

Similar Publications

Objectives: This study aims to explore the perceptions of patients affected by COVID-19 and their families regarding the challenges faced, coping strategies used and lessons learnt in Pakistan.

Design: A qualitative exploratory descriptive approach was used to explore the real-time experiences of the participants.

Setting: The study was carried out in a tertiary care hospital in Karachi, Pakistan.

View Article and Find Full Text PDF

Background: The standard of care for treating opioid use disorder (OUD) during pregnancy includes either buprenorphine or methadone. Although buprenorphine-naloxone presents an alternative due to the reduced risk of misuse , evidence regarding its impact on pregnancy and infant health remains limited. This systematic review and meta-analysis aims to compare buprenorphine-naloxone vs buprenorphine alone for OUD during pregnancy, assessing gestational and neonatal outcomes.

View Article and Find Full Text PDF

Imaging and quantification of placental terminal villi microvasculature and nuclear characteristics in preeclampsia.

Eur J Obstet Gynecol Reprod Biol

March 2025

Department of Genetics and Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands; Interdisciplinary Centre for Clinical Research IZKF, University Hospital RWTH Aachen 52074 Aachen, Germany. Electronic address:

Globally, at least 10 % of maternal deaths, caused by obstetric complications during pregnancy, are linked to preeclampsia or eclampsia. Preeclampsia-induced placental hypoxia leads to vascular injury and syncytial knot formation in terminal villi. Early delivery of preeclampsia placentas complicates comparisons with normotensive term placentas, while the placenta's non-planar structure limits the effectiveness of 2D histology for vascular analysis.

View Article and Find Full Text PDF

Background: Conversational artificial intelligence (AI) allows for engaging interactions, however, its acceptability, barriers, and enablers to support patients with atrial fibrillation (AF) are unknown.

Objective: This work stems from the Coordinating Health care with AI-supported Technology for patients with AF (CHAT-AF) trial and aims to explore patient perspectives on receiving support from a conversational AI support program.

Methods: Patients with AF recruited for a randomized controlled trial who received the intervention were approached for semistructured interviews using purposive sampling.

View Article and Find Full Text PDF

Tobacco 21 (T21) laws (prohibiting tobacco sales under age 21) and flavor restrictions have recently been enacted, yet little is known about the extent to which these policies shifted adolescent tobacco use. To examine the associations between state-level T21 laws and flavor restrictions with adolescent tobacco use overall and by age. We linked state-level T21 laws and flavor restrictions with individual-level data on self-reported levels of cigarette, cigar, and electronic nicotine delivery systems (ENDS) use among 979,477 (500,205 female/479,272 male) 14-18+-year-olds from the 2011-2021 Youth Risk Behavior Surveys.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!